Storm G - Search Results

1

Modulated Electro-Hyperthermia Accelerates Tumor Delivery and Improves Anticancer Activity of Doxorubicin Encapsulated in Lyso-Thermosensitive Liposomes in 4T1-Tumor-Bearing Mice.

Aloss K, Bokhari SMZ, Leroy Viana PH, Giunashvili N, Schvarcz CA, Szénási G, Bócsi D, Koós Z, Storm G, Miklós Z, Benyó Z, Hamar P. Aloss K, et al. Among authors: storm g. Int J Mol Sci. 2024 Mar 7;25(6):3101. doi: 10.3390/ijms25063101. Int J Mol Sci. 2024. PMID: 38542073 Free PMC article.

2

Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses.

Dézsi L, Fülöp T, Mészáros T, Szénási G, Urbanics R, Vázsonyi C, Őrfi E, Rosivall L, Nemes R, Kok RJ, Metselaar JM, Storm G, Szebeni J. Dézsi L, et al. Among authors: storm g. J Control Release. 2014 Dec 10;195:2-10. doi: 10.1016/j.jconrel.2014.08.009. Epub 2014 Aug 19. J Control Release. 2014. PMID: 25148822

3

Synthesis and characterization of biodegradable and thermosensitive polymeric micelles with covalently bound doxorubicin-glucuronide prodrug via click chemistry.

Talelli M, Morita K, Rijcken CJ, Aben RW, Lammers T, Scheeren HW, van Nostrum CF, Storm G, Hennink WE. Talelli M, et al. Among authors: storm g. Bioconjug Chem. 2011 Dec 21;22(12):2519-30. doi: 10.1021/bc2003499. Epub 2011 Nov 3. Bioconjug Chem. 2011. PMID: 22017211

4

Potential pitfalls in in vitro antitumor activity testing of free and liposome-entrapped doxorubicin.

Storm G, Steerenberg PA, van Borssum Waalkes M, Emmen F, Crommelin DJ. Storm G, et al. J Pharm Sci. 1988 Oct;77(10):823-30. doi: 10.1002/jps.2600771002. J Pharm Sci. 1988. PMID: 3236223

5

Liposomal doxorubicin: the good, the bad and the not-so-ugly.

Szebeni J, Fülöp T, Dézsi L, Metselaar B, Storm G. Szebeni J, et al. Among authors: storm g. J Drug Target. 2016 Nov;24(9):765-767. doi: 10.3109/1061186X.2016.1172591. Epub 2016 Apr 27. J Drug Target. 2016. PMID: 27030293

6

Influence of cholesterol inclusion on the doxorubicin release characteristics of lysolipid-based thermosensitive liposomes.

Sadeghi N, Deckers R, Ozbakir B, Akthar S, Kok RJ, Lammers T, Storm G. Sadeghi N, et al. Among authors: storm g. Int J Pharm. 2018 Sep 15;548(2):778-782. doi: 10.1016/j.ijpharm.2017.11.002. Epub 2017 Nov 7. Int J Pharm. 2018. PMID: 29126907

7

Preclinical evaluation of thermosensitive poly(N-(2-hydroxypropyl) methacrylamide mono/dilactate)-grafted liposomes for cancer thermochemotherapy.

van Elk M, van den Dikkenberg JB, Storm G, Hennink WE, Vermonden T, Heger M. van Elk M, et al. Among authors: storm g. Int J Pharm. 2018 Oct 25;550(1-2):190-199. doi: 10.1016/j.ijpharm.2018.08.027. Epub 2018 Aug 18. Int J Pharm. 2018. PMID: 30130606

8

Liposomes as delivery system for doxorubicin in cancer chemotherapy.

Storm G. Storm G. Pharm Weekbl Sci. 1988 Dec 9;10(6):288-90. Pharm Weekbl Sci. 1988. PMID: 3211705 No abstract available.

9

Triggered release of doxorubicin from temperature-sensitive poly(N-(2-hydroxypropyl)-methacrylamide mono/dilactate) grafted liposomes.

van Elk M, Deckers R, Oerlemans C, Shi Y, Storm G, Vermonden T, Hennink WE. van Elk M, et al. Among authors: storm g. Biomacromolecules. 2014 Mar 10;15(3):1002-9. doi: 10.1021/bm401904u. Epub 2014 Feb 6. Biomacromolecules. 2014. PMID: 24476227

10

Investigation of the role of mononuclear phagocytes in the transportation of doxorubicin-containing liposomes into a solid tumor.

Storm G, Van Gessel HJ, Steerenberg PA, Speth PA, Roerdink FH, Regts J, Van Veen M, De Jong WH. Storm G, et al. Cancer Drug Deliv. 1987;4(2):89-104. doi: 10.1089/cdd.1987.4.89. Cancer Drug Deliv. 1987. PMID: 3427554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

558 results

Search Page